With our team spanning 4 states across Aus, it’s always nice when we can see each other in person!
In ACT for the ANZCOP @ausphysics Summer meeting, our Chief Investigator @MeghanSMiller showed our team around the @anuearthscience lab & its earthquake recording equipment!
We are so excited to introduce our new website to the world!
Also, if you are interested in joining our @arc_gov_au Centre, we are currently taking expressions of interest for PhD and Postdoctoral positions via the form on our Open Positions page.
https://t.co/Y7VDtpzeKL
So proud of PhD student Tracy Zhang, who recently presented a stellar oration on the use of preclinical models to track early disease states in Parkinson's Disease. In awe of Tracy's intellect and tenacity @TheFlorey . Huge congratulations 👏👏👏. @Scott_Kolbe
Excited to share our new work using resting-state 7T MRI to study brain network dynamics in people with visual snow syndrome, now published in Human Brain Mapping. https://t.co/0wgOG6hjgW @Scott_Kolbe@RebeccaGlarin@VisualSnowInit@MBCIU_UoM
Strik et al. reveal no evidence of gross brain morphometry changes in people with visual snow syndrome but report widespread changes in grey matter microstructure. @MyrteStrik@Scott_Kolbe https://t.co/OndlhLbQ6y
My shirt’s not very purple this year, but I’m celebrating with double rainbows for #WearItPurpleUQ day @QldBrainInst - for visibility of LGBTQIA+ scientists, and in support of diversity, inclusion, and LGBTQIA+ youth everywhere. Be proud.
We're moving to @UniMelb and have #postdocjobs in #autism modelling and #compneuro. Join our diverse, supportive team of physicists, neuroscientists, and mathematicians as we try to figure out how the #zebrafish brain perceives and responds to the world. Please RT. Details 👇
Kolbe et al. report changes in fibre-specific diffusion MRI measures in 40 clinically stable people with multiple sclerosis over only 18 months and significantly greater sensitivity compared with retinal nerve fibre loss and brain atrophy. https://t.co/W2O5fBtN70 @scott_kolbe
mRNA covid-19 vaccines (pfizer, Moderna) may be better for people with multiple sclerosis taking anti CD20 agents (ocrevus, rituximab, kesimpta) and S1P modulators (gilenya, mayzent, zeposia) as they are more likely to develop protective antibodies. https://t.co/sH9WM7blrP
Congratulations to @kkneurosci at @MonashNeurosci for publishing the first paper from her PhD reviewing how we study the cerebellum in people with MS. The cerebellum is critical for many functions but often ignored! https://t.co/mURMTAOgyW
@LPiccenna Also, the share market bouncing meant that the amount of “surplus” being reported depends largely on which dates you include. Who would have guessed that the share market would rally during the pandemic and then drop afterwards.
A really interesting article on why we shouldn't let large University surpluses get in the way of funding reform for higher education in Australia
https://t.co/lk8ULZXmJP
@LPiccenna TBH I don’t think the seemingly excessive redundancies are an indicator of foul play on the part of Universities. I just think that they overestimated the loss of income they were going to incur.
After a couple of years of analysis, drafting, thinking, redrafting, reviews, re-reviews and copy editing, our paper on measuring axonal loss in MS is now finalised! @MyrteStrik@MengLaw1@anneke_vdw@HelmutButz @MonashNeurosci
https://t.co/Waiea87MSx